MedPath

Onderzoek naar het met een fluorescerende stof zichtbaar maken van de galwegen tijdens operatie voor het verwijderen van de galblaas in patiënten met gecompliceerd galsteenlijde

Recruiting
Conditions
aparoscopy, Cholecystectomy, Bile ducts, Bile duct injury, Infrared, Complicated gallbladder disease
Registration Number
NL-OMON24068
Lead Sponsor
VU University Medical Center, Amsterdam
Brief Summary

ot applicable

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

acute cholecystitis, biliary pancreatitis, choledocholithiasis or cholecystolithiasis resulting in hospital admission, endoscopic retrograde pancreatic-cholangiography (ERCP) or percutaneous gallbladder drainage.

Exclusion Criteria

1. anti-convulsive medication, cyclopropane, bisulphite connexions, haloperidole, diamorphine, pethidine, morphine, nitrofurantoin, opium alkaloids, phenobarbital, phenylbutazon, probenicid, metamizole, rifamycine, methadone, sodium bisulphite

2. Allergy to ICG or Iodine

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Time of identification of the common bile duct and the cystic duct<br /><br>2. Frequency of identification of the common bile duct and cystic duct<br /><br>3. Feasibility of ICG in complicated gallbladder disease <br>
Secondary Outcome Measures
NameTimeMethod
1. Detection of biliary and arterial anatomic variations<br /><br>2. Prevention and detection of bile duct injuries<br>
© Copyright 2025. All Rights Reserved by MedPath